Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Applied Genetic Technologies Corp    AGTC

APPLIED GENETIC TECHNOLOGIES CORP (AGTC)
Mes dernières consult.
Most popular
  Report  
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
02/12/2018 02/13/2018 02/14/2018 02/15/2018 02/16/2018 Date
3.85(c) 3.8(c) 3.8(c) 3.8(c) 3.75(c) Last
65 430 142 001 55 555 63 612 25 557 Volume
-2.53% -1.30% 0.00% 0.00% -1.32% Change
More quotes
Financials ($)
Sales 2018 27,5 M
EBIT 2018 -21,6 M
Net income 2018 -20,3 M
Debt 2018 -
Yield 2018 -
Sales 2019 24,7 M
EBIT 2019 -36,5 M
Net income 2019 -36,1 M
Debt 2019 -
Yield 2019 -
P/E ratio 2018 -
P/E ratio 2019
Capi. / Sales2018 2,50x
Capi. / Sales2019 2,78x
Capitalization 68,8 M
More Financials
Company
Applied Genetic Technologies Corp. is a clinical-stage biotechnology company, which engages in the development of gene therapy products designed to transform the lives of patients with severe diseases in ophthalmology.Its product candidates are designed to treat X-linked retinoschisis,... 
More about the company
Surperformance© ratings of Applied Genetic Technologi
Trading Rating : Investor Rating :
More Ratings
Latest news on APPLIED GENETIC TECHNOLOGI
02/14APPLIED GENETIC TECHNOLOGIES : AGTC Announces Sue Washer, CEO, Elected to Biotec..
PU
02/14APPLIED GENETIC TECHNOLOGIES : AGTC Announces Sue Washer, CEO, Elected to Biotec..
AQ
02/09APPLIED GENETIC TECHNOLOGIES : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL..
AQ
02/09APPLIED GENETIC TECHNOLOGIES CORPORA : AGTC) Files An 8-K Results of Operations ..
AQ
02/09APPLIED GENETIC TECHNOLOGIES (NASDAQ : AGTC) reported earnings of ($0.29) per sh..
AQ
02/09APPLIED GENETIC TECHNOLOGIES : posts 2Q loss
AQ
02/09APPLIED GENETIC TECHNOLOGIES CORP : Results of Operations and Financial Conditio..
AQ
02/09AGTC Announces Financial Results and Business Update for the Quarter Ended De..
GL
02/09APPLIED GENETIC TECHNOLOGIES CORP : Applied Genetic Technologies Corp. to Host E..
AC
02/01AGTC to Host Second Quarter Financial Results Conference Call and Webcast on ..
GL
More news
Sector news : Bio Therapeutic Drugs
02/15French pharma group Ipsen sees more asset purchases, U.S. growth
RE
02/15Oxford BioMedica wins second $100 million gene therapy contract
RE
02/14Bristol-Myers to pay $1.85 billion in cancer deal with Nektar
RE
02/14BRISTOL MYERS SQUIBB : Nektar to Partner on Cancer Therapy
DJ
02/13Drug copies ready to take next bite out of Roche's cancer sales
RE
More sector news : Bio Therapeutic Drugs
Latest Tweets
02/14Cantor Fitzgerald Raises Applied Genetic Technologies FY2018 Earnings Estimat.. 
02/14$CBAY $CDTX $CLVS $FATE $MRNS $ONCE $PIRS $AFMD $AGTC $OVAS $XOMA  
02/13$AGTC - Applied Genetic Technologies #AGTC Receives Outperform Rating from We.. 
02/11$AGTC - Applied Genetic Technologies #AGTC Releases Earnings Results, Misses .. 
02/11Applied Genetic Technologies $AGTC Posts Quarterly Earnings Results, Misses E.. 
More tweets
Qtime:56
News from SeekingAlpha
02/10Finding Biotech Value In All-Time Highs 
02/09Applied Genetic Technologies' (AGTC) CEO Sue Washer on Q2 2018 Results - Earn.. 
02/09Applied Genetic reports Q2 results 
02/09Applied Genetic EPS of -$0.29 
2017After Hours Gainers / Losers 
Chart APPLIED GENETIC TECHNOLOGI
Duration : Period :
Applied Genetic Technologi Technical Analysis Chart | AGTC | US03820J1007 | 4-Traders
Technical analysis trends APPLIED GENETIC TECHNOLOGI
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 6
Average target price 7,60 $
Spread / Average Target 100%
EPS Revisions
Managers
NameTitle
Susan B. Washer President, Chief Executive Officer & Director
William A. Sullivan Chief Financial Officer
Mark S. Shearman Chief Scientific Officer & Vice President
Matthew Feinsod Chief Medical Officer
James Rosen Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
APPLIED GENETIC TECHNOLOGIES CORP5.56%69
GILEAD SCIENCES14.21%106 851
VERTEX PHARMACEUTICALS4.94%39 772
REGENERON PHARMACEUTICALS-12.04%35 529
BIOVERATIV INC91.99%11 201
GENMAB4.28%11 055